[go: up one dir, main page]

PE20131137A1 - Composiciones nasales de vitamina b12 - Google Patents

Composiciones nasales de vitamina b12

Info

Publication number
PE20131137A1
PE20131137A1 PE2013000547A PE2013000547A PE20131137A1 PE 20131137 A1 PE20131137 A1 PE 20131137A1 PE 2013000547 A PE2013000547 A PE 2013000547A PE 2013000547 A PE2013000547 A PE 2013000547A PE 20131137 A1 PE20131137 A1 PE 20131137A1
Authority
PE
Peru
Prior art keywords
vitamin
nasal compositions
composition
ehylucene
ehylucenables
Prior art date
Application number
PE2013000547A
Other languages
English (en)
Inventor
Ketan R Patel
Milan R Patel
Prakashchandra J Shah
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of PE20131137A1 publication Critical patent/PE20131137A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

REFERIDA A UNA COMPOSICION ACUOSA INTRANASAL QUE COMPRENDE METILCOBALAMINA, CO-SOLVENTES/SOLUBILIZADORES TALES COMO GLICOFUROL, PROPILGLICOL, POLIETILENGLICOL O MEZCLAS DE LOS MISMOS EN AGUA Y, OPCIONALMENTE, PRESERVANTES TALES COMO CLORURO DE BENZALCONIO, METILPARABENO, ETILPARABENO, ENTRE OTROS, AGENTES MUCOADHESIVOS TALES COMO ALGINATO DE SODIO, PECTINA, GOMA GUAR, LECTINA, ENTRE OTROS, QUELANTES, HUMECTANTES TALES COMO GLICERINA, SORBITOL, XILITOL, ENTRE OTROS, ANTIOXIDANTES, DONDE DICHA COMPOSICION POSEE UN PH DE ENTRE 5 A 7
PE2013000547A 2010-10-29 2011-10-28 Composiciones nasales de vitamina b12 PE20131137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2169MU2010 2010-10-29

Publications (1)

Publication Number Publication Date
PE20131137A1 true PE20131137A1 (es) 2013-10-03

Family

ID=45350421

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000547A PE20131137A1 (es) 2010-10-29 2011-10-28 Composiciones nasales de vitamina b12

Country Status (21)

Country Link
EP (1) EP2632430B1 (es)
JP (1) JP5843873B2 (es)
CN (1) CN103384513B (es)
AP (1) AP3814A (es)
AR (1) AR083658A1 (es)
BR (1) BR112013010049B1 (es)
CO (1) CO6801717A2 (es)
CU (1) CU24142B1 (es)
DK (1) DK2632430T3 (es)
EA (1) EA024475B1 (es)
ES (1) ES2686299T3 (es)
HU (1) HUE039349T2 (es)
MX (1) MX337365B (es)
MY (1) MY163106A (es)
PE (1) PE20131137A1 (es)
PH (1) PH12013500631B1 (es)
PL (1) PL2632430T3 (es)
PT (1) PT2632430T (es)
UA (1) UA111342C2 (es)
WO (1) WO2012056299A1 (es)
ZA (1) ZA201303024B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474842A4 (en) * 2016-06-24 2020-01-29 Opiant Pharmaceuticals, Inc. COMPOSITIONS, DEVICES AND METHODS FOR TREATING ALKOHOL CONSUMPTION
IL312012A (en) 2016-11-18 2024-06-01 Opiant Pharmaceuticals Inc Compositions and methods for the treatment of opioid overdose
MY202277A (en) 2017-02-06 2024-04-22 Torrent Pharmaceuticals Ltd Intranasal composition of methylcobalamin
EP3634413A1 (en) 2017-06-09 2020-04-15 Exelixis, Inc. Liquid dosage forms to treat cancer
GB202013645D0 (en) 2020-08-31 2020-10-14 Innotesto Bvba Pharmacetical compositions for the nasal administration of a colbalamin compound
AU2022323269A1 (en) 2021-08-04 2024-02-29 Indivior Inc. Compositions and methods for the treatment of opioid overdose
CN120884544A (zh) * 2025-09-28 2025-11-04 湖南状元制药有限公司 甲钴胺组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
ES2074396B1 (es) * 1993-03-24 1996-04-01 Farmalider Sa Sistema de administracion nasal de cianocobalamina (vitamina b12).
BE1007839A6 (nl) * 1993-12-20 1995-10-31 Merkus Franciscus W H M Prof Farmaceutische compositie voor de nasale toediening van hydroxocobalamine.
US7229636B1 (en) * 2003-03-04 2007-06-12 Nastech Pharmaceutical Company Inc. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
ES2356242T3 (es) * 2003-05-07 2011-04-06 EISAI R&D MANAGEMENT CO., LTD. Preparación liofilizada conteniendo metilcobalamina y procedimiento de producción de esta preparación.
JP2009504767A (ja) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンb12鼻用スプレーおよび使用方法
CN101600729A (zh) * 2006-06-23 2009-12-09 帕尔医疗公司 用于鼻内递送的氰钴胺低粘度水性制剂
US20090012039A1 (en) * 2007-03-16 2009-01-08 Stan Kurtz Use of methylcobalamin nasal spray to treat disorders
DE102007012644A1 (de) * 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12

Also Published As

Publication number Publication date
EA201390623A1 (ru) 2013-09-30
CN103384513A (zh) 2013-11-06
MX337365B (es) 2016-02-29
PH12013500631A1 (en) 2013-05-06
WO2012056299A1 (en) 2012-05-03
EP2632430B1 (en) 2018-06-06
AP3814A (en) 2016-09-30
BR112013010049B1 (pt) 2021-07-13
MY163106A (en) 2017-08-15
BR112013010049A2 (pt) 2018-01-09
JP2013540805A (ja) 2013-11-07
ZA201303024B (en) 2014-01-29
JP5843873B2 (ja) 2016-01-13
AP2013006837A0 (en) 2013-04-30
CU24142B1 (es) 2015-12-23
CN103384513B (zh) 2016-01-13
PH12013500631B1 (en) 2019-03-27
CU20130062A7 (es) 2013-10-29
PL2632430T3 (pl) 2018-11-30
ES2686299T3 (es) 2018-10-17
PT2632430T (pt) 2018-10-19
EP2632430A1 (en) 2013-09-04
HUE039349T2 (hu) 2018-12-28
CO6801717A2 (es) 2013-11-29
AR083658A1 (es) 2013-03-13
MX2013004846A (es) 2013-10-01
UA111342C2 (uk) 2016-04-25
DK2632430T3 (en) 2018-09-17
EA024475B1 (ru) 2016-09-30

Similar Documents

Publication Publication Date Title
PE20131137A1 (es) Composiciones nasales de vitamina b12
MX2012002089A (es) Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia.
AR078159A1 (es) Composicion que contiene palmitoil-etanolamida ultra-micronizada .metodo. compuesto.forma polimorfica.
CO6900149A2 (es) Una composición farmacéutica que comprende los fitocanabinoides canabidivarina (cbdv) y canabidiol (cbd)
CR20140185A (es) Derivados de (4-fenilimidazol-2-il)etilamina útiles como moduladores de canal de sodio
AR094643A1 (es) Complejo de haluro de aminoácido y zinc con cisteína
ECSP13013074A (es) Nuevos derivados de piridina
MX2015000813A (es) Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona.
DOP2011000382A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas
CR20150204A (es) Nuevos derivados de piridina
ECSP15010550A (es) Preparación farmacéutica sólida que contiene levotiroxina
AR064830A1 (es) Composiciones para el cuidado oral que comprenden un extracto de hippophae
CR11744A (es) Formulacion liquida para deferiprona con gusto agradable al paladar
AR083769A1 (es) Formulaciones orales que comprenden polietilenglicol
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR093052A1 (es) Composicion para pastas dentales
MX338801B (es) Composiciones de cuidado oral.
ECSP12011837A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
CR11838A (es) Compuestos que contienen nitrogeno tricíclico y su uso como antibacterianos
IN2015DN04073A (es)
MX378056B (es) Composiciones de cuidado oral.
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
MX2013006636A (es) Composiciones bucales y metodo para producir las mismas.
UY34080A (es) Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación
AR084264A1 (es) Composiciones dentifricas orales

Legal Events

Date Code Title Description
FG Grant, registration